BOSTON — Boston University researchers in a groundbreaking study found that those with CTE have a much higher chance of being diagnosed with dementia.

Well, it’snot good news for most people. Some 90% of the population picks their nose — sometimes several times a day. This may seem like a harmless habit, but frequently digging for gold may have dire ...

Most Alzheimer's disease and nearly half of all dementia was associated with variations in the APOE gene, a study of 470,000 older adults suggested. In all-cause dementia, the two alleles were linked ...

Potentially more than 90% of Alzheimer's disease cases would not occur without the contribution of a single gene (APOE), according to a new analysis led by UCL researchers. The scientists also found ...

While there is currently no cure for Alzheimer's disease, a new breakthrough involving a specific frequency of sound and a group of elderly monkeys has sparked hope among researchers. The team from ...

In other words, Alzheimer’s profoundly wounds not just the diagnosed individuals, but their families. That’s why a new study from Northwestern University offers so much hope, because if researchers ...

Alzheimer’s disease blood test developer Quanterix put forward new clinical data from its Simoa assay, which it described as the largest population-based assessment of the condition’s ...

31 December - National weather forecast presented by Clare Nasir.

A team of American scientists claim they have done something miraculous: they “cured” lab mice suffering from Alzheimer’s disease, which has robbed more than seven million Americans, typically 65 ...

Scientists may have pinpointed a way to reverse Alzheimer’s disease in an animal study. The study, led by University Hospitals Cleveland Medical Center, found that restoring a central cellular energy ...

Scientists at Northwestern University used a novel compound to arrest early stages of Alzheimer’s disease in mice — setting the stage, if all goes well, for a groundbreaking treatment in which the ...

Experts see shift toward tailored cancer therapy model Lilly awaiting details of Novo's failed trial Some drug developers target multiple biomarkers Sign up here. Globally, over 55 million people have ...